Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: Q4QBD0
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 262 | 266 | PF00656 | 0.484 |
CLV_C14_Caspase3-7 | 55 | 59 | PF00656 | 0.477 |
CLV_NRD_NRD_1 | 10 | 12 | PF00675 | 0.472 |
CLV_NRD_NRD_1 | 92 | 94 | PF00675 | 0.532 |
CLV_PCSK_FUR_1 | 89 | 93 | PF00082 | 0.653 |
CLV_PCSK_KEX2_1 | 187 | 189 | PF00082 | 0.616 |
CLV_PCSK_KEX2_1 | 91 | 93 | PF00082 | 0.581 |
CLV_PCSK_PC1ET2_1 | 187 | 189 | PF00082 | 0.697 |
CLV_PCSK_SKI1_1 | 272 | 276 | PF00082 | 0.591 |
CLV_PCSK_SKI1_1 | 65 | 69 | PF00082 | 0.529 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.302 |
DOC_CYCLIN_yClb3_PxF_3 | 224 | 230 | PF00134 | 0.403 |
DOC_CYCLIN_yCln2_LP_2 | 205 | 211 | PF00134 | 0.627 |
DOC_CYCLIN_yCln2_LP_2 | 222 | 225 | PF00134 | 0.331 |
DOC_MAPK_gen_1 | 187 | 194 | PF00069 | 0.490 |
DOC_MAPK_MEF2A_6 | 187 | 196 | PF00069 | 0.521 |
DOC_MAPK_MEF2A_6 | 92 | 101 | PF00069 | 0.529 |
DOC_PP2B_LxvP_1 | 156 | 159 | PF13499 | 0.449 |
DOC_PP2B_LxvP_1 | 205 | 208 | PF13499 | 0.637 |
DOC_PP2B_LxvP_1 | 222 | 225 | PF13499 | 0.331 |
DOC_USP7_MATH_1 | 163 | 167 | PF00917 | 0.694 |
DOC_USP7_UBL2_3 | 183 | 187 | PF12436 | 0.567 |
DOC_WW_Pin1_4 | 134 | 139 | PF00397 | 0.459 |
DOC_WW_Pin1_4 | 200 | 205 | PF00397 | 0.441 |
LIG_14-3-3_CanoR_1 | 125 | 129 | PF00244 | 0.411 |
LIG_14-3-3_CanoR_1 | 151 | 157 | PF00244 | 0.476 |
LIG_14-3-3_CanoR_1 | 181 | 186 | PF00244 | 0.715 |
LIG_14-3-3_CanoR_1 | 272 | 281 | PF00244 | 0.374 |
LIG_14-3-3_CanoR_1 | 309 | 314 | PF00244 | 0.478 |
LIG_APCC_ABBA_1 | 108 | 113 | PF00400 | 0.393 |
LIG_FHA_1 | 169 | 175 | PF00498 | 0.568 |
LIG_FHA_2 | 195 | 201 | PF00498 | 0.364 |
LIG_FHA_2 | 260 | 266 | PF00498 | 0.466 |
LIG_LIR_Apic_2 | 133 | 138 | PF02991 | 0.450 |
LIG_LIR_Gen_1 | 218 | 228 | PF02991 | 0.493 |
LIG_LIR_Gen_1 | 254 | 263 | PF02991 | 0.432 |
LIG_LIR_Gen_1 | 58 | 68 | PF02991 | 0.411 |
LIG_LIR_Nem_3 | 113 | 117 | PF02991 | 0.339 |
LIG_LIR_Nem_3 | 218 | 223 | PF02991 | 0.482 |
LIG_LIR_Nem_3 | 254 | 259 | PF02991 | 0.431 |
LIG_LIR_Nem_3 | 5 | 10 | PF02991 | 0.348 |
LIG_LIR_Nem_3 | 58 | 63 | PF02991 | 0.360 |
LIG_PCNA_PIPBox_1 | 1 | 10 | PF02747 | 0.316 |
LIG_PTB_Apo_2 | 67 | 74 | PF02174 | 0.519 |
LIG_SH2_GRB2like | 117 | 120 | PF00017 | 0.462 |
LIG_SH2_STAP1 | 111 | 115 | PF00017 | 0.301 |
LIG_SH2_STAP1 | 117 | 121 | PF00017 | 0.327 |
LIG_SH2_STAP1 | 60 | 64 | PF00017 | 0.413 |
LIG_SH2_STAT3 | 117 | 120 | PF00017 | 0.466 |
LIG_SH2_STAT5 | 135 | 138 | PF00017 | 0.338 |
LIG_SH2_STAT5 | 256 | 259 | PF00017 | 0.416 |
LIG_SH2_STAT5 | 7 | 10 | PF00017 | 0.332 |
LIG_SH3_3 | 218 | 224 | PF00018 | 0.352 |
LIG_SH3_3 | 231 | 237 | PF00018 | 0.297 |
LIG_SH3_3 | 94 | 100 | PF00018 | 0.477 |
LIG_TRFH_1 | 220 | 224 | PF08558 | 0.433 |
LIG_TYR_ITSM | 3 | 10 | PF00017 | 0.319 |
MOD_CK1_1 | 77 | 83 | PF00069 | 0.648 |
MOD_CK2_1 | 141 | 147 | PF00069 | 0.413 |
MOD_CK2_1 | 194 | 200 | PF00069 | 0.346 |
MOD_GlcNHglycan | 105 | 108 | PF01048 | 0.458 |
MOD_GlcNHglycan | 143 | 146 | PF01048 | 0.523 |
MOD_GlcNHglycan | 183 | 186 | PF01048 | 0.718 |
MOD_GlcNHglycan | 253 | 256 | PF01048 | 0.535 |
MOD_GlcNHglycan | 86 | 89 | PF01048 | 0.640 |
MOD_GSK3_1 | 120 | 127 | PF00069 | 0.508 |
MOD_GSK3_1 | 163 | 170 | PF00069 | 0.611 |
MOD_GSK3_1 | 194 | 201 | PF00069 | 0.362 |
MOD_GSK3_1 | 226 | 233 | PF00069 | 0.398 |
MOD_GSK3_1 | 251 | 258 | PF00069 | 0.516 |
MOD_GSK3_1 | 309 | 316 | PF00069 | 0.468 |
MOD_GSK3_1 | 74 | 81 | PF00069 | 0.644 |
MOD_N-GLC_1 | 74 | 79 | PF02516 | 0.633 |
MOD_NEK2_1 | 141 | 146 | PF00069 | 0.484 |
MOD_NEK2_1 | 150 | 155 | PF00069 | 0.443 |
MOD_NEK2_1 | 194 | 199 | PF00069 | 0.385 |
MOD_NEK2_1 | 230 | 235 | PF00069 | 0.424 |
MOD_NEK2_1 | 251 | 256 | PF00069 | 0.447 |
MOD_NEK2_1 | 79 | 84 | PF00069 | 0.732 |
MOD_NEK2_2 | 46 | 51 | PF00069 | 0.398 |
MOD_PKA_2 | 124 | 130 | PF00069 | 0.393 |
MOD_PKA_2 | 150 | 156 | PF00069 | 0.558 |
MOD_PKA_2 | 213 | 219 | PF00069 | 0.368 |
MOD_Plk_1 | 284 | 290 | PF00069 | 0.517 |
MOD_Plk_1 | 74 | 80 | PF00069 | 0.616 |
MOD_Plk_4 | 124 | 130 | PF00069 | 0.377 |
MOD_Plk_4 | 226 | 232 | PF00069 | 0.395 |
MOD_Plk_4 | 3 | 9 | PF00069 | 0.303 |
MOD_ProDKin_1 | 134 | 140 | PF00069 | 0.463 |
MOD_ProDKin_1 | 200 | 206 | PF00069 | 0.448 |
TRG_ENDOCYTIC_2 | 111 | 114 | PF00928 | 0.344 |
TRG_ENDOCYTIC_2 | 256 | 259 | PF00928 | 0.380 |
TRG_ENDOCYTIC_2 | 60 | 63 | PF00928 | 0.347 |
TRG_ENDOCYTIC_2 | 7 | 10 | PF00928 | 0.372 |
TRG_ER_diArg_1 | 89 | 92 | PF00400 | 0.598 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5K0 | Leptomonas seymouri | 58% | 100% |
A0A0S4JDC4 | Bodo saltans | 34% | 100% |
A0A1X0NXD8 | Trypanosomatidae | 44% | 100% |
A0A3R7MEG1 | Trypanosoma rangeli | 45% | 100% |
A0A3S5H7B7 | Leishmania donovani | 95% | 100% |
A4HCQ8 | Leishmania braziliensis | 81% | 99% |
A4I083 | Leishmania infantum | 95% | 100% |
C9ZV00 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 100% |
E9AW47 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
V5ASF5 | Trypanosoma cruzi | 43% | 100% |